RBC Capital Positive on Alnylam Pharmaceuticals (ALNY): 'HELIOS-B Hits Convincingly Across the Board, Materially Exceeding Expectations'
Go back to RBC Capital Positive on Alnylam Pharmaceuticals (ALNY): 'HELIOS-B Hits Convincingly Across the Board, Materially Exceeding Expectations'| Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) | Delayed: 245.51 +6.15 (2.57%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $239.36 | 52 Week High | $109.10 | |||
| Open | $242.60 | 52 Week Low | $31.38 | |||
| Day High | $245.63 | P/E | N/A | |||
| Day Low | $239.50 | EPS | $-1.45 | |||
| Volume | 954,013 | |||||
